Alogliptin CAS: 850649-61-5
| Product Parameters | |
|---|---|
| Catalog No. | BA6B1C |
| CAS.RN | 850649-61-5 |
| Molecular Formula | C18H21N5O2 |
| Molecular Weight | 339.39 g/mol |
| Purity | NLT 98% |
Product Overview
Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor primarily used in the research and development and production of diabetes treatments. It is a key intermediate for novel oral hypoglycemic drugs. This product is suitable for all stages of drug development, from small-scale preparation to pilot-scale amplification and commercial production, and is widely used in the process development and optimization of antidiabetic drugs. Its stable structure and mature synthetic route provide customers with high-quality active pharmaceutical ingredient support, helping them smoothly transition from the laboratory to industrialization.
Applications
- Diabetes Drug Development
- DPP-4 Inhibitor Synthesis
- Customized Supply of Drug Intermediates
- Process Route Optimization and Scale-up Production
- Pharmaceutical Enterprise API Procurement
Quality & Supply Capability
English Name: Alogliptin Properties: White to off-white crystalline powder with good thermal and chemical stability. The core functional groups are amide and piperazine rings, meeting pharmaceutical-grade API standards. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific details. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide sample supply, small-scale preparation, pilot-scale amplification, and customized batch production services. We offer flexible supply solutions based on customer requirements for purity, impurity control, packaging specifications, delivery time, and quality documentation. Simultaneously, we provide comprehensive technical support from laboratory R&D to scale-up production, helping customers advance process development, route optimization, and project transformation, ensuring product quality and delivery efficiency.
Why Choose Bioncan
Focused on supplying DPP-4 inhibitor APIs, with strong product specialization. Full-scale supply capability covering all stages from laboratory to commercial production. Provides complete quality control documentation to meet GMP and regulatory requirements. Supports customized needs, adjusting purity, impurity control, and packaging specifications according to customer requirements. Provides process optimization and scale-up technical support to ensure smooth project progress for our clients.
Intermediates of Alogliptin
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA6B1C | Alogliptin API | 850649-61-5 |
| BK2H9Z | (R)-3-Piperidinamine dihydrochloride | 334618-23-4 |
| BK5V56 | 2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]benzonitrile | 865758-96-9 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 850649-61-5, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
